Beese Fulmer Investment Management, Inc. Abbott Laboratories Transaction History
Beese Fulmer Investment Management, Inc.
- $1.08 Billion
- Q2 2024
A detailed history of Beese Fulmer Investment Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Beese Fulmer Investment Management, Inc. holds 95,892 shares of ABT stock, worth $10.8 Million. This represents 0.92% of its overall portfolio holdings.
Number of Shares
95,892
Previous 95,200
0.73%
Holding current value
$10.8 Million
Previous $10.8 Million
7.91%
% of portfolio
0.92%
Previous 1.04%
Shares
28 transactions
Others Institutions Holding ABT
# of Institutions
3,137Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.7 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.8 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.38 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.09 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.45 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $197B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...